|
[1]
|
Bjorkstén, B., Sepp, E., Julge, K., et al. (2001) Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology, 108, 516-520. doi:10.1067/mai.2001.118130
|
|
[2]
|
Das, R.R. (2011) Cesarean delivery, antibiotic exposure, and probiotics: Relationship with childhood asthma. Journal of Allergy and Clinical Immunology, 128, 1133-1134.
doi:10.1016/j.jaci.2011.07.043
|
|
[3]
|
Newburg, D.S. (2000) Oligosaccharides in human milk and bacterial colonization. Journal of Pediatric Gastroenterology and Nutrition, 30, S8-S17.
|
|
[4]
|
Matsuki, T., Watanabe, K., Tanaka, R., et al. (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Applied and Environmental Microbiology, 65, 4506-4512.
|
|
[5]
|
Harmsen, H.J., Wildeboer-Veloo, A.C., Raangs, G.C., et al. (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition, 30, 61-67.
doi:10.1097/00005176-200001000-00019
|
|
[6]
|
Yoshioka, H., Iseki, K. and Fujita, K. (1983) Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics, 72, 317-321.
|
|
[7]
|
Kalliomaki, M., Kirjavainen, P., Eerola, E., et al. (2001) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. Journal of Allergy and Clinical Immunology, 107, 129-134.
doi:10.1067/mai.2001.111237
|
|
[8]
|
Kirjavainen, P.V., Arvola, T., Salminen, S.J. and Isolauri, E. (2002) Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut, 51, 51-55. doi:10.1136/gut.51.1.51
|
|
[9]
|
Sepp, E., Julge, K., Mikelsaar, M. and Bj?rkstén, B. (2005) Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clinical & Experimental Allergy, 35, 1141-1146.
doi:10.1111/j.1365-2222.2005.02315.x
|
|
[10]
|
Ozdemir,O. (2009) Gut flora development in infancy and its effect on immune system. Journal of Pediatric Infection, 3, 202-203.
|
|
[11]
|
Metchnikoff, E. (1907) The prolongation of life: Optimistic studies. G. P. Putnam & Sons, London.
|
|
[12]
|
Food and Agriculture Organization, World Health Organization (2001) Report of joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO Report, World Health Organization, 10-11.
|
|
[13]
|
Ozdemir, O. (2009) Any benefits of probiotics in allergic disorders? Allergy and Asthma Proceedings, 31, 103-111.
doi:10.2500/aap.2010.31.3313
|
|
[14]
|
Cabana, M.D., McKean, M., Wong, A.R., et al. (2007) Examining the hygiene hypothesis: The Trial of infant probiotic supplementation. Paediatric and Perinatal Epidemiology, 21, 23-28.
doi:10.1111/j.1365-3016.2007.00881.x
|
|
[15]
|
Ljungberg, M., Korpela, R., Ilonen, J., et al. (2006) Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes: The PRODIA study. Annals of the New York Academy of Sciences, 1079, 360-364. doi:10.1196/annals.1375.055
|
|
[16]
|
Vaarala, O, Atkinson, M.A. and Neu, J. (2008) The “Perfect Storm” for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes, 57, 2555-2562.
doi:10.2337/db08-0331
|
|
[17]
|
Bach, J.F. (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. The New England Journal of Medicine, 347, 911-920.
doi:10.1056/NEJMra020100
|
|
[18]
|
Petrovsky, N. (2010) Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus. Nature Reviews Endocrinology, 6, 131-138.
doi:10.1038/nrendo.2009.273
|
|
[19]
|
Boerner, B.P. and Sarvetnick, N.E. (2011) Type 1 diabetes: role of intestinal microbiome in humans and mice. Annals of the New York Academy of Sciences, 1243, 103-118.
doi:10.1111/j.1749-6632.2011.06340.x
|
|
[20]
|
Prescott, S.L., Macaubas, C., Holt, B.J., et al. (1998) Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. Journal of Immunology, 160, 4730-4737.
|
|
[21]
|
Schwartz, R.H. (2005) Natural regulatory T cells and self-tolerance. Nature Immunology, 6, 327-330.
doi:10.1038/ni1184
|
|
[22]
|
Billmann-Born, S., Till, A., Arlt, A., et al. (2011) Genome- wide expression profiling identifies an impairment of negative feedback signals in the Crohn’s disease-associated NOD2 variant L1007fsinsC. Journal of Immunology, 186, 4027-4038. doi:10.4049/jimmunol.1000085
|
|
[23]
|
Walsh, K.P., Brady, M.T., Finlay, C.M., et al. (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. Journal of Immunology, 183, 1577-1586.
doi:10.4049/jimmunol.0803803
|
|
[24]
|
Sgouroudis, E., Kornete, M. and Piccirillo, C.A. (2011) IL-2 production by dendritic cells promotes Foxp3(+) regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity, 44, 406-414.
doi:10.3109/08916934.2010.536795
|
|
[25]
|
Okada, H., Kuhn, C., Feillet, H. and Bach, J.F. (2010) The “hygiene hypothesis” for autoimmune and allergic diseases: An update. Clinical & Experimental Immunology, 160, 1-9. doi:10.1111/j.1365-2249.2010.04139.x
|
|
[26]
|
Tlaskalová-Hogenová, H., Stepánková, R., Hudcovic, T., et al. (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters, 93, 97-108.
doi:10.1016/j.imlet.2004.02.005
|
|
[27]
|
Matsuzaki, T., Takagi, A., Ikemura, H., et al. (2007) Intestinal microflora: probiotics and autoimmunity. Journal of Nutrition, 137, 798S-802S.
|
|
[28]
|
Kubota, A., He, F., Kawase, M., et al. (2011) Diversity of intestinal bifidobacteria in patients with Japanese cedar pollinosis and possible influence of probiotic intervention. Current Microbiology, 62, 71-77.
doi:10.1007/s00284-010-9667-5
|
|
[29]
|
Canche-Pool, E.B., Cortez-Gómez, R., Flores-Mejía, R., et al. (2008) Probiotics and autoimmunity: An evolutionary perspective. Medical Hypotheses, 70, 657-660.
doi:10.1016/j.mehy.2007.07.008
|
|
[30]
|
de Kort, S., Keszthelyi, D. and Masclee, A.A. (2011) Leaky gut and diabetes mellitus: what is the link? Obesity Reviews, 12, 449-458.
doi:10.1111/j.1467-789X.2010.00845.x
|
|
[31]
|
Kim, N.Y. and Ji, G.E. (2012) Effects of probiotics on the prevention of atopic dermatitis. Korean Journal of Pediatrics, 55, 193-201. doi:10.3345/kjp.2012.55.6.193
|
|
[32]
|
?zdemir, ?. (2010) Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clinical & Experimental Immunology, 160, 295-304. doi:10.1111/j.1365-2249.2010.04109.x
|
|
[33]
|
Majamaa, H. and Isolauri, E. (1997) Probiotics. A novel approach in the management of food allergy. Journal of Allergy and Clinical Immunology, 99, 179-185.
doi:10.1016/S0091-6749(97)70093-9
|
|
[34]
|
Kalliom?ki, M., Salminen, S., Poussa, T. and Isolauri, E. (2007) Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo- controlled trial. Journal of Allergy and Clinical Immunology, 119, 1019-1021. doi:10.1016/j.jaci.2006.12.608
|
|
[35]
|
Singh, B. and Rabinovitch, A. (1993) Influence of microbial agents on the development and prevention of autoimmune diabetes. Autoimmunity, 15, 209-213.
doi:10.3109/08916939309019929
|
|
[36]
|
Brugman, S., Klatter, F.A., Visser, J.T., et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1diabetes? Diabetologia, 49, 2105-2108. doi:10.1007/s00125-006-0334-0
|
|
[37]
|
Sudo, N., Sawamura, S., Tanaka, K., et al. (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. The Journal of Immunology, 159, 1739-1745.
|
|
[38]
|
Miele, E., Pascarella, F., Giannetti, E., et al. (2009) Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. The American Journal of Gastroenterology, 104, 437- 443. doi:10.1038/ajg.2008.118
|
|
[39]
|
Dotan, I. and Rachmilewitz, D. (2005) Probiotics in inflammatory bowel disease: Possible mechanisms of action. Current Opinion in Gastroenterology, 21, 426-430.
|
|
[40]
|
Sawada, J., Morita, H., Tanaka, A., et al. (2007) Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clinical & Experimental Allergy, 37, 296-303.
doi:10.1111/j.1365-2222.2006.02645.x
|
|
[41]
|
Cebra, J.J. (1999) Influences of microbiota on intestinal immune system development. The American Journal of Clinical Nutrition, 69, 1046S-1051S.
|
|
[42]
|
Sistek, D., Kelly, R., Wickens, K., et al. (2006) Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clinical & Experimental Allergy, 36, 629-633. doi:10.1111/j.1365-2222.2006.02485.x
|
|
[43]
|
Pessi, T., Isolauri, E., Sutas, Y., Kankaanranta, H., Moilanen, E. and Hurme, M. (2001) Suppression of T cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. Immunopharmacology, 1, 211-218.
doi:10.1016/S1567-5769(00)00018-7
|
|
[44]
|
Kaila, M., Isolauri, E., Soppi, E., et al. (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatric Research, 32, 141-144.
doi:10.1203/00006450-199208000-00002
|
|
[45]
|
Isolauri, E., Sütas, Y., Kankaanp??, P., et al. (2001) Probiotics: Effects on immunity. The American Journal of Clinical Nutrition, 73, 444S-450S.
|
|
[46]
|
Inoue, R., Nishio, A., Fukushima, Y. and Ushida, K. (2007) Oral treatment with probiotic Lactobacillus johnsonii NCC533 (La1) for a specific part of the weaning period prevents the development of atopic dermatitis induced after maturation in model mice, NC/Nga. British Journal of Dermatology, 156, 499-509.
doi:10.1111/j.1365-2133.2006.07695.x
|
|
[47]
|
Salminen, S.J., Gueimonde, M. and Isolauri, E. (2005) Probiotics that modify disease risk. Journal of Nutrition, 135, 1294-1298.
|
|
[48]
|
Takahashi, N., Kitazawa, H., Iwabuchi, N., et al. (2006) Immunostimulatory oligodeoxynucleotide from Bifido- bacterium longum suppresses Th2 immune responses in a murine model. Clinical & Experimental Immunology, 145, 130-138. doi:10.1111/j.1365-2249.2006.03111.x
|
|
[49]
|
Braat, H., Van Den Brande, J., Van Tol, E., et al. (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. The American Journal of Clinical Nutrition, 80, 1618-1625.
|
|
[50]
|
Maassen, C.B., Van Holten-Neelen, C., Balk, F., et al. (2000) Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine, 18, 2613-2623.
doi:10.1016/S0264-410X(99)00378-3
|
|
[51]
|
Shida, K., Nanno, M., Nagata, S. (2011) Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes, 2,109-114.
doi:10.4161/gmic.2.2.15661
|
|
[52]
|
Niers, L.E., Timmerman, H.M., Rijkers, G.T., et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which downregulate T helper type 2 cytokines. Clinical & Experimental Allergy, 35, 1481-1489.
doi:10.1111/j.1365-2222.2005.02375.x
|
|
[53]
|
Kruisselbrink, A., Heijne Den Bak-Glashouwer, M.J., Havenith, C.E., et al. (2001) Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clinical & Experimental Immunology, 126, 2-8.
doi:10.1046/j.1365-2249.2001.01642.x
|
|
[54]
|
West, C.E., Hammarstr?m, M.L. and Hernell, O. (2009) Probiotics during weaning reduce the incidence of eczema. Pediatric Allergy and Immunology, 20, 430-437.
doi:10.1111/j.1399-3038.2009.00745.x
|
|
[55]
|
Kim, J.Y., Choi, Y.O. and Ji, G.E. (2008) Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. Journal of Microbiology and Biotechnology, 18, 1393-1400.
|
|
[56]
|
Sunada, Y., Nakamura, S. and Kamei, C. (2008) Effect of Lactobacillus acidophilus strain L-55 on the development of atopic dermatitis-like skin lesions in NC/Nga mice. International Immunopharmacology, 8, 1761-1766.
doi:10.1016/j.intimp.2008.08.011
|
|
[57]
|
Shida, K., Makino, K. and Morishita, A. (1998) Lactobacillus casei inhibits antigen induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. International Archives of Allergy and Immunology, 115, 278-287. doi:10.1159/000069458
|
|
[58]
|
Watanabe, T., Hamada, K., Tategaki, A., et al. (2009) Oral administration of lactic acid bacteria isolated from traditional South Asian fermented milk ‘dahi’ inhibits the development of atopic dermatitis in NC/Nga mice. Journal of Nutritional Science and Vitaminology, 55, 271-278.
doi:10.3177/jnsv.55.271
|
|
[59]
|
Hayashi, A., Kimura, M., Nakamura, Y. and Yasui, H. (2009) Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk. Journal of Dairy Research, 76, 158-164.
doi:10.1017/S0022029908003725
|
|
[60]
|
Won, T.J., Kim, B, Lim, Y.T., et al. (2011) Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC?/?Nga mice. Journal of Applied Microbiology, 110, 1195-1202.
doi:10.1111/j.1365-2672.2011.04981.x
|
|
[61]
|
Ogawa, T., Hashikawa, S., Asai, Y., et al. (2006) A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS Immunology and Medical Microbiology, 46, 400- 409. doi:10.1111/j.1574-695X.2006.00046.x
|
|
[62]
|
Wakabayashi, H., Nariai, C., Takemura, F., et al. (2008) Dietary supplementation with lactic acid bacteria atenuates the development of atopic-dermatitis-like skin lesions in NC/Nga mice in a strain-dependent manner. International Archives of Allergy and Immunology, 145, 141-151. doi:10.1159/000108139
|
|
[63]
|
Segawa, S., Hayashi, A., Nakakita, Y., et al. (2008) Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates the development of dermatitis and inhibits immunoglobulin E production in atopic dermatitis model NC/Nga mice. Biological & Pharmaceutical Bulletin, 31, 884-889. doi:10.1248/bpb.31.884
|
|
[64]
|
Tanaka, A., Jung, K., Benyacoub, J., et al. (2009) Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-gamma. Experimental Dermatology, 18, 1022-1027. doi:10.1111/j.1600-0625.2009.00895.x
|
|
[65]
|
Thomas, D.J., Husmann, R.J., Villamar, M., et al. (2011) Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLoS ONE, 6, e16577.
doi:10.1371/journal.pone.0016577
|
|
[66]
|
Pohjavuori E, Viljanen M, Korpela R, et al. (2004) Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. Journal of Allergy and Clinical Immunology, 114, 131-136.
doi:10.1016/j.jaci.2004.03.036
|
|
[67]
|
Prescott, S.L., Dunstan, J.A., Hale, J., et al. (2005) Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clinical & Experimental Allergy, 35, 1557-1564. doi:10.1111/j.1365-2222.2005.02376.x
|
|
[68]
|
Rosenfeldt, V., Benfeldt, E., Nielsen, S.D., et al. (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology, 111, 389-395. doi:10.1067/mai.2003.389
|
|
[69]
|
Brouwer, M.L., Wolt-Plompen, S.A., Dubois, A.E., et al. (2006) No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clinical & Experimental Allergy, 36, 899-906.
doi:10.1111/j.1365-2222.2006.02513.x
|
|
[70]
|
Pessi, T., Sütas, Y., Hurme, M. and Isolauri, E. (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clinical & Experimental Allergy, 30, 1804-1808.
doi:10.1046/j.1365-2222.2000.00948.x
|
|
[71]
|
Betsi, G.I., Papadavid, E. and Falagas, M.E. (2008) Probiotics for the treatment or prevention of atopic dermatitis: A review of the evidence from randomized controlled trials. American Journal of Clinical Dermatology, 9, 93-103. doi:10.2165/00128071-200809020-00002
|
|
[72]
|
Woo, S.I., Kim, J.Y., Lee, Y.J., et al. (2010) Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Annals of Allergy, Asthma & Immunology, 104, 343-348.
doi:10.1016/j.anai.2010.01.020
|
|
[73]
|
Inoue, R., Otsuka, M., Nishio, A. and Ushida, K. (2007) Primary administration of Lactobacillus johnsonii NCC533 in weaning period suppresses the elevation of proinflammatory cytokines and CD86 gene expressions in skin lesions in NC/Nga mice. FEMS Immunology and Medical Microbiology, 50, 67-76.
doi:10.1111/j.1574-695X.2007.00233.x
|
|
[74]
|
Marschan, E., Kuitunen, M., Kukkonen, K., et al. (2008) Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clinical & Experimental Allergy, 38, 611-618.
doi:10.1111/j.1365-2222.2008.02942.x
|
|
[75]
|
Kobayashi, T., Suzuki, T., Kaji, R., et al. (2012) Probiotic upregulation of peripheral IL-17 responses does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis mouse models. Immunopharmacology and Immunotoxicology, 34, 423-433.
doi:10.3109/08923973.2010.617755
|
|
[76]
|
So, J.S., Kwon, H.K., Lee, C.G., et al. (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Molecular Immunolo- gy, 45, 2690-2699. doi:10.1016/j.molimm.2007.12.010
|
|
[77]
|
Lavasani, S., Dzhambazov, B., Nouri, M., et al. (2010) A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE, 5, e9009.
doi:10.1371/journal.pone.0009009
|
|
[78]
|
Niers, L.E., Hoekstra, M.O., Timmerman, H.M., et al. (2007) Selection of probiotic bacteria for prevention of allergic diseases: Immunomodulation of neonatal dendritic cells. Clinical & Experimental Immunology, 149, 344- 352. doi:10.1111/j.1365-2249.2007.03421.x
|
|
[79]
|
Hart, A.L., Lammers, K., Brigidi, P., et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut, 53, 1602-1609.
doi:10.1136/gut.2003.037325
|
|
[80]
|
Smits, H.H., Engering, A., Van Der Kleij, D., et al. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. Journal of Allergy and Clinical Immunology, 115, 1260-1267.
doi:10.1016/j.jaci.2005.03.036
|
|
[81]
|
Issazadeh-Navikas, S., Teimer, R. and Bockermann, R. (2012) Influence of dietary components on regulatory T cells. Molecular Medicine, 18, 95-110.
doi:10.2119/molmed.2011.00311
|
|
[82]
|
Feleszko, W., Jaworska, J., Rha, R.D., et al. (2007) Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clinical & Experimental Allergy, 37, 498-505.
doi:10.1111/j.1365-2222.2006.02629.x
|
|
[83]
|
Di Giacinto, C., Marinaro, M., Sanchez, M., et al. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta- bearing regulatory cells. The Journal of Immunology, 174, 3237-3246.
|
|
[84]
|
Hacini-Rachinel, F., Gheit, H., Le Luduec, J.B., et al. (2009) Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE, 4, e4903. doi:10.1371/journal.pone.0004903
|
|
[85]
|
Fujimura, T., Okuyama, R., Ito, Y. and Aiba, S. (2008) Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. British Journal of Dermatology, 158, 1256-1263.
doi:10.1111/j.1365-2133.2008.08504.x
|
|
[86]
|
Kwon, H.K., Lee, C.G., So, J.S., et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the United States of America, 107, 2159-2164.
doi:10.1073/pnas.0904055107
|
|
[87]
|
Taylor, A.L., Hale, J., Hales, B.J., et al. (2007) FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatric Allergy and Immunology, 18, 10-19. doi:10.1111/j.1399-3038.2006.00483.x
|
|
[88]
|
Weise, C., Zhu, Y., Ernst, D., et al. (2011) Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. Experimental Dermatology, 20, 805-809. doi:10.1111/j.1600-0625.2011.01326.x
|
|
[89]
|
Gerasimov, S.V., Vasjuta, V.V., Myhovych, O.O. and Bondarchuk, L.I. (2010) Probiotic supplement reduces atopic dermatitis in preschool children: A randomized, double-blind, placebo-controlled, clinical trial. American Journal of Clinical Dermatology, 11, 351-361.
doi:10.2165/11531420-000000000-00000
|
|
[90]
|
Chapat, L., Chemin, K., Dubois, B., et al. (2004) Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. European Journal of Immunology, 34, 2520-2528.
doi:10.1002/eji.200425139
|
|
[91]
|
Roessler, A., Friedrich, U., Vogelsang, H., et al. (2008) The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clinical & Experimental Allergy, 38, 93-102.
|
|
[92]
|
Gareau, M.G., Sherman, P.M. and Walker, W.A. (2010) Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology, 7, 503-514. doi:10.1038/nrgastro.2010.117
|
|
[93]
|
Rachmilewitz, D., Katakura, K., Karmeli, F., et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology, 126, 520-528.
doi:10.1053/j.gastro.2003.11.019
|
|
[94]
|
Hoarau, C., Lagaraine, C., Martin, L., et al. (2006) Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. Journal of Allergy and Clinical Immunology, 117, 696-702. doi:10.1016/j.jaci.2005.10.043
|
|
[95]
|
Forsythe, P., Inman, M.D. and Bienenstock, J. (2007) Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. American Journal of Respiratory and Critical Care Medicine, 175, 561-569.
doi:10.1164/rccm.200606-821OC
|
|
[96]
|
Aumeunier, A., Grela, F., Ramadan, A., et al. (2010) Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS ONE, 5, e11484.
doi:10.1371/journal.pone.0011484
|